000 01298 a2200397 4500
005 20250510205800.0
264 0 _c19750826
008 197508s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(75)91948-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKaye, J P
245 0 0 _aTriglyceride-production rates in patients with type-4 hypertriglyceridaemia.
_h[electronic resource]
260 _bLancet (London, England)
_cMay 1975
300 _a1005-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aBody Height
650 0 4 _aBody Weight
650 0 4 _aFasting
650 0 4 _aHumans
650 0 4 _aHyperlipidemias
_xblood
650 0 4 _aLipoprotein Lipase
_xantagonists & inhibitors
650 0 4 _aLipoproteins, VLDL
_xantagonists & inhibitors
650 0 4 _aMale
650 0 4 _aMetabolic Clearance Rate
_xdrug effects
650 0 4 _aMiddle Aged
650 0 4 _aProtamines
_xpharmacology
650 0 4 _aRabbits
650 0 4 _aSulfates
_xpharmacology
650 0 4 _aTriglycerides
_xblood
700 1 _aGalton, D J
773 0 _tLancet (London, England)
_gvol. 1
_gno. 7914
_gp. 1005-7
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(75)91948-0
_zAvailable from publisher's website
999 _c47589
_d47589